Literature DB >> 21094350

Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial.

James C Blankenship1, Kimberly A Skelding, Thomas D Scott, Peter B Berger, Helen Parise, Bruce R Brodie, Bernhard Witzenbichler, Giulio Gaugliumi, Jan Z Peruga, Alexandra J Lansky, Roxana Mehran, Gregg W Stone.   

Abstract

Primary percutaneous coronary intervention (PCI) is the optimal method of reperfusion when performed expeditiously. Factors contributing to delays in PCI for ST-segment elevation myocardial infarction (STEMI) have not been thoroughly characterized or quantified. We sought to identify the factors associated with the delays to reperfusion in patients with STEMI undergoing primary PCI. Primary PCI was performed in 3,340 patients with STEMI in the international, multicenter Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction trial. Multivariate analysis was used to identify independent predictors of delay in achieving reperfusion from 38 baseline and procedural variables. A total of 905 patients (27.1%) presented to non-PCI hospitals and were subsequently transferred; the remainder presented to PCI hospitals. The most powerful independent predictor of the interval from symptom onset to arrival at the PCI hospital and the first door-to-balloon time was an initial presentation at a non-PCI hospital (median incremental 58- and 54-minute delay, respectively, both p < 0.001). Other independent predictors of prolonged door-to-balloon times included presentation with respiratory failure (42-minute incremental delay, p = 0.003), presentation during off-work hours (11-minute incremental delay, p < 0.001), and co-morbid conditions such as diabetes and heart failure. In conclusion, among patients undergoing primary PCI, presentation to a non-PCI hospital was the variable associated with the greatest delay to reperfusion. Systems of care that encourage ambulance diagnosis and direct delivery of patients with STEMI to a PCI hospital might shorten the overall door-to-balloon times and improve the clinical outcomes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21094350     DOI: 10.1016/j.amjcard.2010.07.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Interhospital transfer due to failed prehospital diagnosis for primary percutaneous coronary intervention: an observational study on incidence, predictors, and clinical impact.

Authors:  Karim D Mahmoud; Youlan L Gu; Maarten W Nijsten; Ronald de Vos; Wybe Nieuwland; Felix Zijlstra; Hans L Hillege; Iwan C van der Horst; Bart Jgl de Smet
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

2.  Incidence and Prognostic Impact of Respiratory Support in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Thomas S Metkus; Aiham Albaeni; Nisha Chandra-Strobos; Shaker M Eid
Journal:  Am J Cardiol       Date:  2016-10-08       Impact factor: 2.778

3.  Exploring the treatment delay in the care of patients with ST-elevation myocardial infarction undergoing acute percutaneous coronary intervention: a cross-sectional study.

Authors:  Joppe Tra; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  BMC Health Serv Res       Date:  2015-08-21       Impact factor: 2.655

4.  Outcomes of Physician-Staffed Versus Non-Physician-Staffed Helicopter Transport for ST-Elevation Myocardial Infarction.

Authors:  Sverrir I Gunnarsson; Joseph Mitchell; Mary S Busch; Brenda Larson; S Michael Gharacholou; Zhanhai Li; Amish N Raval
Journal:  J Am Heart Assoc       Date:  2017-02-02       Impact factor: 5.501

5.  Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction-an analysis from China Acute Myocardial Infarction (CAMI) registry.

Authors:  Rui Fu; Si-Dong Li; Chen-Xi Song; Jing-Ang Yang; Hai-Yan Xu; Xiao-Jin Gao; Yi Xu; Jian-Ping Zeng; Jun-Nong Li; Ke-Fei Dou; Yue-Jin Yang
Journal:  J Geriatr Cardiol       Date:  2019-05       Impact factor: 3.327

6.  Guideline-Based Critical Care Pathway Improves Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome.

Authors:  Jo-Jo Hai; Chun-Ka Wong; Ka-Chun Un; Ka-Lam Wong; Zhe-Yu Zhang; Pak-Hei Chan; Yui-Ming Lam; Wing-Sze Chan; Cheung-Chi Lam; Chor-Cheung Tam; Yiu-Tung Wong; See-Yue Yung; Ki-Wan Chan; Chung-Wah Siu; Chu-Pak Lau; Hung-Fat Tse
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

7.  [Delays in the management of acute coronary syndromes with ST-ST segment elevation in Ouagadougou and factors associated with an extension of these delays: a cross-sectional study about 43 cases collected in the CHU-Yalgado Ouédraogo].

Authors:  Nobila Valentin Yameogo; André Samadoulougou; Georges Millogo; Koudougou Jonas Kologo; Karim Kombassere; Boubacar Jean Yves Toguyeni; Patrice Zabsonre
Journal:  Pan Afr Med J       Date:  2012-12-30

8.  Trends in treatment delays for patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Salla Helve; Juho Viikilä; Mika Laine; Jyrki Lilleberg; Ilkka Tierala; Tuomo Nieminen
Journal:  BMC Cardiovasc Disord       Date:  2014-09-10       Impact factor: 2.298

9.  Multicentre analysis of current ST-elevation myocardial infarction acute care pathways.

Authors:  Joppe Tra; Carolien de Blok; Ineke van der Wulp; Martine C de Bruijne; Cordula Wagner
Journal:  Open Heart       Date:  2017-01-30

10.  Influence of Geographical Location on Access to Reperfusion Therapies and Mortality of Patients with STEMI in Sergipe: VICTIM Register.

Authors:  Jeferson Cunha Oliveira; Guilherme José Dos Santos Ferreira; Jussiely Cunha Oliveira; Ticiane Clair Remacre Munareto Lima; Ikaro Daniel de Carvalho Barreto; Laís Costa Souza Oliveira; Larissa Andreline Maia Arcelino; Antônio Carlos Sousa; José Augusto Soares Barreto-Filho
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.